Individual deals - 20 different companies sell leronlimab for 20 different indications. That really wouldn't work that well. That's why once we have revenue coming in we need to handle distribution in house (the preferable) or pay a single distributor.

I do like it that we have a 3 year contract term for COVID-19. Which makes me think that outside of HIV we will distribute ourselves eventually.